| corporate management --- scientific managment --- visit our scientists |
|||||
|
|||||
|
Board of Directors
|
|||||
|
|
|||||
|
|||||
|
|||||
|
|||||
|
Scientific Review Committee ...conducts annual reveiws of research projects, core facilities and budgets RESEARCH PROJECTS
CORE FACILITIES Roy Gravel (Chair) University of Calgary Denis Bulman Ottawa Hospital Research Institute Daniel Sinnett Hôpital Ste. Justine Brenda Gallie Ontario Cancer Institute Rima Rozen Montreal Childrens Hospital Research Institute Strategic Fund Review Committee ... identifies CGDN research projects with commercial potential. John Gillard Aegera Therapeutics Inc. Richard Glickman Consultant Margaret Moore Consultant John Clement QLT Inc. Michael Dennis SignalGene Inc Kevin O'Brien-Fehr Glaxo Wellcome Rui Avelar Haywood Securities Dr. Norman Dovichi University of Washington Training Committee .. oversees the CGDN fellowships and summer student awards program. Phil Hieter Centre for Molecular Medicine & Therapeutics Michael Walter University of Alberta Barbara Triggs-Raine University of Manitoba Johanna Rommens Hospital for Sick Children Steven Scherer Hospital for Sick Children Rima Rozen Montreal Children's Hospital Research Institute |
|||||
|
|
|||||
|
Core Technology Facility Directors ... are senior scientists who head CGDN labs which provide efficient and cost effective access to sophisticated technologies. |
|||||
|
|||||
|
Network Scholars ... are young scientists who are mentored by CGDN. Dr. Dennis Bulman Ottawa Hospital Research Institute Dr. Elise Héon Eye Research Institute of Canada Dr. Daniel Sinnett Hôpital Ste-Justine Dr. Rachel Wevrick University of Alberta Dr. Susan Andrew University of Alberta Dr. Celia Greenwood McGill University Dr. Moira Glerum University of Alberta Dr. Christopher Pearson Hospital for Sick Children Dr. Bruce Rannala University of Alberta |